3f9n: Difference between revisions
From Proteopedia
Jump to navigationJump to search
No edit summary |
No edit summary |
||
| Line 1: | Line 1: | ||
[[Image:3f9n.png|left|200px]] | [[Image:3f9n.png|left|200px]] | ||
{{STRUCTURE_3f9n| PDB=3f9n | SCENE= }} | {{STRUCTURE_3f9n| PDB=3f9n | SCENE= }} | ||
===Crystal structure of chk1 kinase in complex with inhibitor 38=== | ===Crystal structure of chk1 kinase in complex with inhibitor 38=== | ||
{{ABSTRACT_PUBMED_19155174}} | {{ABSTRACT_PUBMED_19155174}} | ||
==About this Structure== | ==About this Structure== | ||
[[3f9n]] is a 1 chain structure of [[Serine/threonine protein kinase]] with sequence from [http://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=3F9N OCA]. | |||
==See Also== | |||
*[[Serine/threonine protein kinase|Serine/threonine protein kinase]] | |||
==Reference== | ==Reference== | ||
<ref group="xtra">PMID: | <ref group="xtra">PMID:019155174</ref><references group="xtra"/> | ||
[[Category: Homo sapiens]] | [[Category: Homo sapiens]] | ||
[[Category: Non-specific serine/threonine protein kinase]] | [[Category: Non-specific serine/threonine protein kinase]] | ||
| Line 33: | Line 24: | ||
[[Category: Chek1]] | [[Category: Chek1]] | ||
[[Category: Chk1]] | [[Category: Chk1]] | ||
[[Category: Dna damage]] | [[Category: Dna damage]] | ||
[[Category: Dna repair]] | [[Category: Dna repair]] | ||
| Line 40: | Line 30: | ||
[[Category: Nucleus]] | [[Category: Nucleus]] | ||
[[Category: Phosphoprotein]] | [[Category: Phosphoprotein]] | ||
[[Category: Serine/threonine-protein kinase]] | [[Category: Serine/threonine-protein kinase]] | ||
[[Category: Transferase]] | [[Category: Transferase]] | ||
Revision as of 12:11, 25 July 2012
Crystal structure of chk1 kinase in complex with inhibitor 38
Template:ABSTRACT PUBMED 19155174
About this Structure
3f9n is a 1 chain structure of Serine/threonine protein kinase with sequence from Homo sapiens. Full crystallographic information is available from OCA.
See Also
Reference
- Converso A, Hartingh T, Garbaccio RM, Tasber E, Rickert K, Fraley ME, Yan Y, Kreatsoulas C, Stirdivant S, Drakas B, Walsh ES, Hamilton K, Buser CA, Mao X, Abrams MT, Beck SC, Tao W, Lobell R, Sepp-Lorenzino L, Zugay-Murphy J, Sardana V, Munshi SK, Jezequel-Sur SM, Zuck PD, Hartman GD. Development of thioquinazolinones, allosteric Chk1 kinase inhibitors. Bioorg Med Chem Lett. 2009 Feb 15;19(4):1240-4. Epub 2008 Dec 24. PMID:19155174 doi:10.1016/j.bmcl.2008.12.076